Sitomegalovirus (CMV) ga qarshi IgG antitanalari
Kod:18026
| Kabi | Sitomegalovirus (CMV) ga qarshi IgG antitanalari |
|---|
Tahlil ma'lumotlari
Tadqiqot usuli
- Elektrokimyoluminessent immunoanaliz (ECLIA)
Kutilayotgan natija topshirish vaqti
1–2 kun
Maxsus tayyorlik
- Do not smoke for 30 minutes before the blood draw.
Qanday foydalanish
Sitomegalovirus (CMV) ga qarshi IgG testi (Anti‑CMV IgG) avvalgi CMV ta’sirlanishi va immun holatini tasdiqlash, hamda tegishli klinik kontekstda CMV infeksiyasini tashxislashga yordam berish uchun qo‘llanadi. Epstein–Barr virusi bo‘yicha tadqiqotlar manfiy bo‘lganda, mononukleozga o‘xshash kasallikning boshqa sabablaridan CMV ni farqlashga ham yordam beradi. Homiladorlikda CMV IgG CMV IgM va CMV IgG avidligi bilan birgalikda talqin qilinadi, bu ona infeksiyasining vaqtini taxmin qilish va tug‘ma CMV xavfini aniqlashga xizmat qiladi. Immuniteti susaygan shaxslarda serologiya molekulyar natijalar va klinik topilmalar bilan birgalikda baholanadi.
Cheklovlar
Sitomegalovirus — inson gerpesvirusidir, umrboqiy latentlikni o‘rnatadi va reaktivatsiyalanish ehtimoli mavjud. Immunokompetent shaxslarda birlamchi infeksiya ko‘pincha simptomsiz kechadi yoki mononukleozga o‘xshash kasallik tarzida namoyon bo‘ladi. Yuqish so‘lak, siydik, qon va sperma orqali, shuningdek vertikal tarzda onadan bolaga bachadonda, tug‘ruq vaqtida yoki emizish orqali sodir bo‘ladi. Homiladorlik davrida onaning birlamchi infeksiyasi tug‘ma CMV uchun eng yuqori xavfni keltirib chiqaradi; bu infeksiyalarning bir qismida uchraydi va mikrosefaliya, intrakranial kalsifikatsiyalar, gepatosplenomegaliya, toshma, sensorinevral eshitish yo‘qolishi, neyro‑rivojlanish buzilishi yoki homilaning nobud bo‘lishiga olib kelishi mumkin. Immunodefitsit sharoitida og‘ir kasallik rivojlanishi mumkin, jumladan, retinit, kolit, ezofagit va ensefalit. CMV‑ga xos IgG birlamchi infeksiyadan keyingi bir necha hafta ichida paydo bo‘ladi va keyin saqlanib qoladi; IgG avidligini baholash yaqinda bo‘lib o‘tgan birlamchi infeksiyani (past avidlik) o‘tmishdagi infeksiya yoki reaktivatsiyadan (yuqori avidlik) farqlashga yordam beradi.
| Referens oraliq | — |
|---|---|
| Ko'rsatmalar | Prepregnancy or prenatal evaluation of CMV immunity and risk, particularly when fetal ultrasound reveals anomalies, Assessment of suspected CMV infection in patients with immunocompromise, Mononucleosis‑like syndrome with negative Epstein–Barr virus testing |
Namunangiz talablari
| Namunangiz | Namuna ko'rsatilmagan |
|---|---|
| Container | Testga qarab |
References
Adler SP. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol. 2011:1–9.
Goldman's Cecil Medicine. 24th ed. Goldman L, Schafer AI, eds. Saunders Elsevier; 2011.
Lazzarotto T, et al. Why is cytomegalovirus the most frequent cause of congenital infection? Expert Rev Anti Infect Ther. 2011;9(10):841–843.
Belshe RB, ed. Textbook of Human Virology. Littleton, MA: PSG Publishing Co; 1984.
Drew WL. Controversies in viral diagnosis. Rev Infect Dis. 1986 Sep–Oct;8(5):814–824. PubMed 3024292.
Korones SB. Uncommon virus infections of the mother, fetus, and newborn: influenza, mumps, and measles. Clin Perinatol. 1988 Jun;15(2):259–272. PubMed 3288423.
Lennette DA. Preparation of specimens for virological examination. In: Balows A, Hausler WJ, et al, eds. Manual of Clinical Microbiology. 5th ed. Washington, DC: ASM Press; 1991:818–821.
Pfaller MA, Caliendo AM, Versalovic J. Detection of herpes simplex virus in CSF by PCR. In: Isenberg HD, ed. Clinical Microbiology Procedures Handbook. 2nd ed. Washington, DC: ASM Press; 2004:12.2.3.51–12.2.3.61.